A retrospective study of efficacy of romosozumab in patients with osteoporosis
Latest Information Update: 23 Jun 2022
Price :
$35 *
At a glance
- Drugs Romosozumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 23 Jun 2022 New trial record
- 04 Jun 2022 Results presented at the 23rd Annual Congress of the European League Against Rheumatism